Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Diet Rich in Tomatoes May Lower Breast Cancer Risk

By BiotechDaily International staff writers
Posted on 08 Jan 2014
A diet rich in tomatoes may help protect at-risk postmenopausal women from breast cancer, according to new research. Moreover, fruits were found to raise levels of hormone involved in regulating blood sugar and fat.

The new findings were published December 2013, online, ahead of print in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Breast cancer risk increases in postmenopausal women as their body mass index climbs. The study’s researchers discovered that eating a diet high in tomatoes had a beneficial effect on the level of hormones that play a role in regulating fat and sugar metabolism. “The advantages of eating plenty of tomatoes and tomato-based products, even for a short period, were clearly evident in our findings,” said the study’s first author, Adana Llanos, PhD, MPH, who is an assistant professor of epidemiology at Rutgers University (New Brunswick, NJ, USA). “Eating fruits and vegetables, which are rich in essential nutrients, vitamins, minerals, and phytochemicals such as lycopene, conveys significant benefits. Based on these data, we believe regular consumption of at least the daily recommended servings of fruits and vegetables would promote breast cancer prevention in an at-risk population.”

The longitudinal crossover research studied the effects of both tomato-rich and soy-rich diets in a group of 70 postmenopausal women. The women ate tomato products containing at least 25 mg of lycopene daily for 10 weeks. For a separate 10-week period, the participants consumed at least 40 g of soy protein daily. Before each test period began, the women were instructed to not eat both tomato and soy products for two weeks.

When they ate the tomato-rich diet, participants’ levels of adiponectin, a hormone involved in controlling blood sugar and fat levels, climbed 9%. The effect was slightly stronger in women who had a lower body mass index. “The findings demonstrate the importance of obesity prevention,” Dr. Llanos said. “Consuming a diet rich in tomatoes had a larger impact on hormone levels in women who maintained a healthy weight.”

The soy diet was tied to a decrease in study participants’ adiponectin levels. Researchers first hypothesized that a diet containing large amounts of soy could be part of the reason that Asian women have lower rates of breast cancer than women in the United States, but any beneficial effect may be limited to specific ethnic groups, according to Dr. Llanos.

Related Links:

Rutgers University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.